X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (211) 211
female (126) 126
male (121) 121
hematology (117) 117
oncology (116) 116
middle aged (115) 115
adult (107) 107
aged (90) 90
rituximab (84) 84
chemotherapy (75) 75
antineoplastic combined chemotherapy protocols - therapeutic use (74) 74
treatment outcome (72) 72
cancer (54) 54
lymphomas (49) 49
aged, 80 and over (48) 48
disease-free survival (44) 44
follicular lymphoma (42) 42
survival (42) 42
non-hodgkins-lymphoma (41) 41
abridged index medicus (37) 37
prognosis (36) 36
lymphoma (34) 34
neoplasm staging (33) 33
young adult (33) 33
care and treatment (32) 32
antineoplastic combined chemotherapy protocols - administration & dosage (31) 31
disease (31) 31
antineoplastic agents - therapeutic use (30) 30
therapy (30) 30
transplantation (30) 30
doxorubicin - administration & dosage (29) 29
hemic and lymphatic diseases (29) 29
lymphoma, large b-cell, diffuse - drug therapy (29) 29
survival rate (29) 29
cyclophosphamide - administration & dosage (28) 28
follow-up studies (28) 28
trial (27) 27
vincristine - administration & dosage (27) 27
antibodies, monoclonal - therapeutic use (26) 26
lymphoma, follicular - drug therapy (26) 26
survival analysis (26) 26
prednisone - administration & dosage (25) 25
risk factors (25) 25
antibodies, monoclonal, murine-derived (24) 24
antineoplastic combined chemotherapy protocols - adverse effects (24) 24
b-cell lymphoma (24) 24
antineoplastic agents - administration & dosage (23) 23
clinical trials as topic (22) 22
hematology, oncology and palliative medicine (22) 22
adolescent (21) 21
antibodies, monoclonal, murine-derived - therapeutic use (21) 21
immune system diseases (21) 21
non-hodgkin-lymphoma (21) 21
cohort studies (20) 20
cyclophosphamide (20) 20
lymphoma, follicular - mortality (20) 20
lymphoma, follicular - therapy (20) 20
recurrence (20) 20
analysis (19) 19
lymphoma, follicular - pathology (19) 19
lymphoma, large b-cell, diffuse - pathology (19) 19
lymphoma, non-hodgkin - therapy (19) 19
phase-ii (19) 19
elderly-patients (18) 18
lymphoma, non-hodgkin - drug therapy (18) 18
antibodies, monoclonal, murine-derived - administration & dosage (17) 17
outcomes (17) 17
research (17) 17
antibodies, monoclonal - administration & dosage (16) 16
antineoplastic agents (16) 16
doxorubicin - therapeutic use (16) 16
hodgkin disease - drug therapy (16) 16
non-hodgkin's lymphomas (16) 16
risk (16) 16
stem-cell transplantation (16) 16
vincristine (16) 16
combined modality therapy (15) 15
disease progression (15) 15
hodgkin disease - pathology (15) 15
kaplan-meier estimate (15) 15
plus rituximab (15) 15
rituximab - administration & dosage (15) 15
transplantation, autologous (15) 15
antimitotic agents (14) 14
cyclophosphamide - therapeutic use (14) 14
non-hodgkin lymphoma (14) 14
original reports (14) 14
prospective studies (14) 14
radiotherapy (14) 14
chop (13) 13
clinical trials (13) 13
diagnosis (13) 13
hodgkin lymphoma (13) 13
immunology (13) 13
lymphoma, large b-cell, diffuse - mortality (13) 13
lymphoma, large b-cell, diffuse - therapy (13) 13
multicenter (13) 13
prednisone - therapeutic use (13) 13
united states (13) 13
vincristine - therapeutic use (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 26, pp. 2531 - 2544
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 1019 - 1026
Summary Background Present first-line therapy for diffuse large B-cell lymphoma, a subtype of non-Hodgkin lymphoma, is rituximab, cyclophosphamide,... 
Hematology, Oncology and Palliative Medicine | THERAPY | OLDER PATIENTS | ONCOLOGY | FEBRILE NEUTROPENIA | PCI-32765 | CHRONIC LYMPHOCYTIC-LEUKEMIA | CLASSIFICATION | RANDOMIZED CONTROLLED-TRIAL | TARGETING BTK | ELDERLY-PATIENTS | CHEMOTHERAPY | Doxorubicin - therapeutic use | Pyrazoles - therapeutic use | Prognosis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Dose-Response Relationship, Drug | Young Adult | Non-Randomized Controlled Trials as Topic | Aged, 80 and over | Adult | Female | Lymphoma, Non-Hodgkin - drug therapy | Pyrazoles - adverse effects | Severity of Illness Index | Antigens, CD20 - immunology | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Administration, Oral | Rituximab | Survival Rate | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Antigens, CD20 - drug effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Lymphoma, Non-Hodgkin - diagnosis | Care and treatment | Anthracyclines | Cyclophosphamide | Prednisone | Corticosteroids | Tumors
Journal Article
by Zhou, Naihui and Jiang, Yuxiang and Bergquist, Timothy R and Lee, Alexandra J and Kacsoh, Balint Z and Crocker, Alex W and Lewis, Kimberley A and Georghiou, George and Nguyen, Huy N and Hamid, Md Nafiz and Davis, Larry and Dogan, Tunca and Atalay, Volkan and Rifaioglu, Ahmet S and Dalkıran, Alperen and Cetin Atalay, Rengul and Zhang, Chengxin and Hurto, Rebecca L and Freddolino, Peter L and Zhang, Yang and Bhat, Prajwal and Supek, Fran and Fernández, José M and Gemovic, Branislava and Perovic, Vladimir R and Davidović, Radoslav S and Sumonja, Neven and Veljkovic, Nevena and Asgari, Ehsaneddin and Mofrad, Mohammad R.K and Profiti, Giuseppe and Savojardo, Castrense and Martelli, Pier Luigi and Casadio, Rita and Boecker, Florian and Schoof, Heiko and Kahanda, Indika and Thurlby, Natalie and McHardy, Alice C and Renaux, Alexandre and Saidi, Rabie and Gough, Julian and Freitas, Alex A and Antczak, Magdalena and Fabris, Fabio and Wass, Mark N and Hou, Jie and Cheng, Jianlin and Wang, Zheng and Romero, Alfonso E and Paccanaro, Alberto and Yang, Haixuan and Goldberg, Tatyana and Zhao, Chenguang and Holm, Liisa and Törönen, Petri and Medlar, Alan J and Zosa, Elaine and Borukhov, Itamar and Novikov, Ilya and Wilkins, Angela and Lichtarge, Olivier and Chi, Po-Han and Tseng, Wei-Cheng and Linial, Michal and Rose, Peter W and Dessimoz, Christophe and Vidulin, Vedrana and Dzeroski, Saso and Sillitoe, Ian and Das, Sayoni and Lees, Jonathan Gill and Jones, David T and Wan, Cen and Cozzetto, Domenico and Fa, Rui and Torres, Mateo and Warwick Vesztrocy, Alex and Rodriguez, Jose Manuel and Tress, Michael L and Frasca, Marco and Notaro, Marco and Grossi, Giuliano and Petrini, Alessandro and Re, Matteo and Valentini, Giorgio and Mesiti, Marco and Roche, Daniel B and Reeb, Jonas and Ritchie, David W and Aridhi, Sabeur and Alborzi, Seyed Ziaeddin and Devignes, Marie-Dominique and Koo, Da Chen Emily and Bonneau, Richard and Gligorijević, Vladimir and Barot, Meet and Fang, Hai and Toppo, Stefano and Lavezzo, Enrico and ...
Genome biology, ISSN 1474-760X, 2019, Volume 20, Issue 1, pp. 1 - 23
...Author(s): Naihui Zhou[sup.1,2] , Yuxiang Jiang[sup.3] , Timothy R. Bergquist[sup.4] , Alexandra J. Lee[sup.5] , Balint Z. Kacsoh[sup.6,7] , Alex W. Crocker... 
CANDIDA-ALBICANS | Critical assessment | Community challenge | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | Protein function prediction | GENETICS & HEREDITY | Biofilm | LIBRARY | Long-term memory | ONTOLOGY | GENERATION | IDENTIFICATION | Databases | Distributed, Parallel, and Cluster Computing | Bioinformatics | Machine Learning | Artificial Intelligence | Computer Science
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2014, Volume 32, Issue 1, pp. 44 - 50
Purpose Aurora A kinase (AAK) is overexpressed in aggressive lymphomas and can correlate with more histologically aggressive forms of disease. We therefore... 
SURVIVAL | IN-VITRO | ADVANCED SOLID TUMORS | RITUXIMAB PLUS CYCLOPHOSPHAMIDE | ONCOLOGY | SYNTHETIC LETHAL | MYC | VINCRISTINE | MLN8237 | LEUKEMIA CELLS | NF-KAPPA-B | Burkitt Lymphoma - enzymology | Recurrence | Lymphoma, Follicular - drug therapy | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Aurora Kinase A - antagonists & inhibitors | Lymphoma, T-Cell - enzymology | Antineoplastic Agents - adverse effects | Adult | Female | Antineoplastic Agents - pharmacokinetics | Molecular Targeted Therapy - methods | Burkitt Lymphoma - drug therapy | Protein Kinase Inhibitors - pharmacokinetics | Azepines - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Drug Administration Schedule | Pyrimidines - administration & dosage | Lymphoma, Large B-Cell, Diffuse - enzymology | Lymphoma, Mantle-Cell - drug therapy | Treatment Outcome | Azepines - therapeutic use | Protein Kinase Inhibitors - administration & dosage | Lymphoma, T-Cell - drug therapy | Lymphoma, Mantle-Cell - enzymology | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Lymphoma, Follicular - enzymology | Aged | Azepines - pharmacokinetics | Azepines - administration & dosage | Hema13 | ORIGINAL REPORTS
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2016, Volume 34, Issue 17, pp. 2020 - 2027
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 3, pp. 314 - 320
Purpose Advanced follicular lymphomas (FL) are considered incurable with conventional chemotherapy and there is no consensus on the best treatment approach.... 
Original Reports | Hema14
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 18, pp. 1681 - 1690
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2011, Volume 17, Issue 19, pp. 6112 - 6117
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2013, Volume 31, Issue 6, pp. 684 - 691
Journal Article
JNCI: Journal of the National Cancer Institute, ISSN 0027-8874, 08/2019, Volume 111, Issue 8, pp. 757 - 759
Journal Article